These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 381947)

  • 41. Mode of action of coronary arterial relaxation by prostacyclin.
    Holzmann S; Kukovetz WR; Schmidt K
    J Cyclic Nucleotide Res; 1980; 6(6):451-60. PubMed ID: 6163806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostacyclin stimulation of dog arterial cyclic AMP levels.
    Miller OV; Aiken JW; Hemker DP; Shebuski RJ; Gorman RR
    Prostaglandins; 1979 Dec; 18(6):915-25. PubMed ID: 232764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.
    Dusting GJ; Moncada S; Vane JR
    Prostaglandins; 1977 Jan; 13(1):3-15. PubMed ID: 841106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
    Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
    Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery.
    Hedlund H; Andersson KE
    J Urol; 1985 Dec; 134(6):1245-50. PubMed ID: 3903226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
    Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
    Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The bradykinin-induced coronary vasodilation. Evidence for an additional prostacyclin-independent mechanism.
    Schrör K; Metz U; Krebs R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 307(3):213-21. PubMed ID: 386139
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
    Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
    Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dependence of cardiac eicosanoid effects on changes of calcium concentration.
    Mentz P; Pawelski KE
    Biomed Biochim Acta; 1984; 43(8-9):S167-70. PubMed ID: 6393963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR; Verrier RL; Lown B
    Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles.
    Edwards RM
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F779-84. PubMed ID: 3923841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
    Hyman AL; Chapnick BM; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5711-5. PubMed ID: 414226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin.
    Sterin-Borda L; Franchi AM; Borda ES; Del Castillo E; Gimeno MF; Gimeno AL
    Eur J Pharmacol; 1984 Aug; 103(3-4):211-21. PubMed ID: 6436040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasodilation produced by prostacyclin (PGI2) and 9(O)-thiaprostacyclin (PGI2-S) in the canine femoral circulation.
    Horii D; Kanayama T; Mori M; Shibasaki M; Ikegami S
    Eur J Pharmacol; 1978 Oct; 51(3):313-6. PubMed ID: 361420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.
    Dembinska-Kiec A; Rücker W; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):67-70. PubMed ID: 6154247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of prostacyclin (PGI2) on the smooth muscles of the guinea-pig stomach.
    Ishizawa M
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):80-9. PubMed ID: 7034665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostacyclin increases cAMP in coronary arteries.
    Kukovetz WR; Holzmann S; Wurm A; Pöch G
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):469-76. PubMed ID: 231612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.